COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

Date
2021Author(s)
Rodriguez-Morales, A.J.
Sah, R.
Millan-Oñate, J.
Gonzalez, A.
Montenegro-Idrogo, J.J.
Scherger, S.
Franco-Paredes, C.
Henao-Martínez, A.F.
Metadata
Show full item recordAbstract
Invasive mycoses represent opportunistic infections occurring predominantly among highly immunosuppressed individuals, including those with advanced human immunodeficiency virus-associated immunosuppression, uncontrolled diabetes mellitus, drug-induced immunosuppression during transplantation, autoimmune disorders, or hematological malignancies. The overuse of high-dose glucocorticoids and the administration of highly immunosuppressive drugs such as inhibitors of the Janus kinase inhibitors or IL-6 receptor inhibitors to treat patients with the coronavirus disease 2019 (COVID-19) are responsible in part for the increasing number of life-threatening opportunistic infections identified in this patient population...
Collections
- Editorial [44]
